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C BY-NC-Abstract Cu(II) complexes have been synthesized from the Schiff base ligands derived from fur-
furlyidene-4-aminoantipyrine and aniline (L1)/p-nitroaniline (L2)/p-hydroxyaniline (L3). They were
characterized using analytical and spectral techniques. All the Cu(II) complexes exhibit square pla-
nar geometry. The X-band ESR spectra of the copper complexes in DMSO solution at 300 and
77 K were recorded and their salient features are reported. The in vitro biological screening effects
of the investigated compounds were tested against the bacterial species, Staphylococcus aureus,
Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris and Pseudomonas aeruginosa and fungal
species, Aspergillus niger, Rhizopus stolonifer, Aspergillus ﬂavus, Rhizoctonia bataicola and Candida
albicans by serial dilution method. A comparative study of inhibition values of the Schiff base
ligands and their complexes indicate that the complexes exhibit higher antimicrobial activity than
the Schiff base ligands. Superoxide dismutase and reducing power activities of the copper complexes
have also been studied. Depending on the molecular structure, the [CuL2(OAc)2] complex possess
promising SOD mimetic activities.
ª 2011 King Saud University. Production and hosting by Elsevier B.V.29474150.
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ND license.1. Introduction
The increasing microbial resistance to antibiotics in use nowa-
days necessitates the search for new compounds with potential
effects against pathogenic bacteria and fungi. The most specta-
cular advances in medicinal chemistry have been made when
heterocyclic compounds played an important role in regulating
biological activities. Heterocyclic moieties can be found in a
large number of compounds which display biological activity.
Antipyrine (N-heterocyclic compound) and its derivatives ex-
hibit a wide range of biological activities and applications
(Hosler et al., 1980; Ismail et al., 2009; Farghaly and Hozza,
1980). Antipyrine is a marker in the study of transfer and
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et al., 2002) and antipyrine metabolites are reported to show
a positive correlation with plasma ﬁbronectin level in monitor-
ing patients with chronic liver illness (HBC, HCV and alcohol-
related disease) (Grieco et al., 1998). Because of their interest-
ing structural features as well as the biological activity, a wide
range of metal complexes derived from antipyrine derivatives
have been reported (El-Dissouky et al., 1997; Mohamed
et al., 2005; Eleni et al., 2011). Pyrazole-based ligands display
variable complexing behaviour and a variety of coordination
possibilities to metal centers (Iqbal et al., 2007).
Coordination of organic compound with metal, i.e., chela-
tion causes drastic change in the biological property of the li-
gand and also the metal moiety (Sorenson, 1987; Macias et al.,
2003; Chandra and Gupta, 2005). It has been reported that che-
lation is the cause and cure of many diseases including cancer.
Schiff base of 4-aminoantipyrine and its metal complexes have
a variety of applications in biological, clinical, analytical and
pharmacological areas.
Metal complexes that can undergo such redox cycling can
function as superoxide scavengers. Copper is the active metal
center in the best studied SOD and many copper complexes
have been synthesized and tested for SOD-like activity (Anac-
ona et al., 2004). Metal complex mediated cleavage of DNA is
a subject of continued interest (Lee et al., 2002), particularly,
toward development of new metallo-pharmaceuticals. The
importance of copper complexes for promoting such studies
in development of copper-based drugs is well established. Cop-
per complexes with imines have deserved much attention,
probably because of their ability to intercalate between the
bases of DNA and to participate in catalytic cycles with usual
reducing and oxidizing agents in biological medium.
Copper complexes with imines have deserved much atten-
tion, probably because of their ability to intercalate between
the bases of DNA and to participate in catalytic cycles with
usual reducing and oxidizing agents in biological medium
and Cu(II) is also involved in the causation and cure of cancer
(Engleka and Maciog, 1994). This prompted us to synthesize a
new series of heterocyclic compounds containing the antipyrinyl
moiety from the Schiff bases derived from furfurlyidene-
4-aminoantipyrine and aniline (L1)/p-nitroaniline (L2)/p-
hydroxyaniline (L3) and their copper complexes. They were
characterized using analytical and spectral techniques. Further-
more, their biological studies like antimicrobial, reducing power
and superoxide dismutase activities were performed.
2. Experimental
2.1. Materials and spectral measurements
The chemicals used were of AnalaR grade. Furfuraldehyde
and 4-aminoantipyrine were obtained from Sigma. Copper(II)
acetate was obtained from Merck. Acetonitrile was dried over
phosphorous pentoxide and distilled repeatedly to obtain a
highly pure product. The synthetic pathway for the com-
pounds is shown in Scheme 1.
Micro-analytical data, 1H NMR and FAB mass spectra of
the compounds were recorded at the Regional Sophisticated
Instrumentation Center, Central Drug Research Institute
(RSIC, CDRI), Lucknow. The amount of metal present in
the metal complexes was estimated using ammonium oxalatemethod. The 1H NMR (400 MHz) spectra of the ligands were
recorded using tetramethylsilane (TMS) as internal standard.
The FAB mass spectrum of the Schiff base ligands and their
complexes were recorded on a JEOL SX 102/DA-6000 mass
spectrometer/data system using argon/xenon (6 kV, 10 mA)
as the FAB gas. The accelerating voltage was 10 kV and the
spectrawere recordedat room temperature usingm-nitrobenzyl-
alcohol (NBA) as the matrix. Molar conductance of the copper
complexes was measured in DMSO solution using a coronation
digital conductivity meter. The IR spectra of the Schiff base li-
gands and their complexes were recorded on a Perkin-Elmer
783 spectrophotometer in 4000–200 cm1 range using KBr disc.
Electronic spectra of synthesized compounds were recorded
with a Systronics 2201 Double beam UV–Vis spectrophotome-
ter in the 200–1100 nm region. The magnetic susceptibility val-
ues were calculated using the relation leff = 2.83(vm Æ T). The
diamagnetic corrections were made by Pascal’s constant and
Hg[Co(SCN)4]was used as a calibrant. The ESR spectra of the
complexes were recorded at 300 and 77 K on a Varian E112
X-band spectrometer. Cyclic voltammetric measurements were
performed using a glassy carbonworking electrode, Pt wire aux-
iliary electrode and anAg/AgCl reference electrode. Tetrabutyl-
ammoniumperchlorate (TBAP) was used as the supporting
electrolyte. All solutions were purged with N2 for 30 min prior
to each set of experiments. The computer controlled X-ray dif-
fractometer system JEOL JDX 8030 was used to record powder
data for the copper complexes at Central Elelectrochemical Re-
search Institute, Karaikudi.
2.2. Preparation of Schiff bases
Furfurlyidene-4-aminoantipyrine was prepared by the conden-
sation of furfuraldehyde and 4-aminoantipyrine. An ethanolic
solution of furfurlyidene-4-aminoantipyrine and aniline (L1)/p-
nitroaniline (L2)/p-hydroxyaniline (L3) (0.01 mol) was boiled
under reﬂux for ca. 6 h. The solvent was then reduced to
one-third its volume and the resulting solution was cooled to
0 C. The yellow solid product formed was removed by ﬁltra-
tion and recrystallised from ethanol.
L1: Yield: 56%; elemental analysis: Anal. Calcd. for
C22H20N4O: C, 74.14; H, 5.66; N, 15.72. Found: C, 74.10;
H, 5.62; N, 15.69%; UV–Vis: 286 nm (n–p* transition).
L2: Yield: 62%; elemental analysis: Anal. Calcd. for
C22H19N5O3: C, 65.83; H, 4.77; N, 17.45. Found: C,
65.80; H, 4.72; N, 17.48%; UV–Vis: 336 nm (n–p*
transition).
L3: Yield: 42%; elemental analysis: Anal. Calcd. for
C22H20N4O2: C, 70.95; H, 5.41; N, 15.41. Found: C,
70.92; H, 5.39; N, 15.38%; UV–Vis: 342 nm (n–p*
transition).
2.3. Preparation of copper(II) complexes
A solution of copper(II) acetate(s) and the Schiff base(s)
(0.01 M) in ethanol (50 ml) was stirred for ca. 3 h using a mag-
netic stirrer. The precipitated complex was ﬁltered, washed
thoroughly with ethanol and dried in vacuum. The Schiff base
ligands and their copper complexes were characterized using






















Scheme 1 Outline the synthesis of Schiff base ligands. Where X = H (L1), p-NO2 (L
2) and p-OH (L3).
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C26H26CuN4O5: Cu, 11.81; C, 58.04; H, 4.87; N, 10.41.
Found: Cu, 11.79; C, 58.00; H, 4.82; N, 10.38%;
leff(BM) = 1.86; Km(mho cm
2 mol1) = 22; m/z= 538;
UV–Vis: 482 nm.
[CuL2(OAc)2]: Elemental analysis: Anal. Calcd. for
C26H25CuN5O7: Cu, 19.21; C, 53.56; H, 4.32; N, 12.01.
Found: Cu, 19.18; C, 53.52; H, 4.29; N, 11.97%;
leff(BM) = 1.82; Km(mho cm
2 mol1) = 34; m/z= 584;
UV–Vis: 342 and 538 nm.
[CuL3(OAc)2]: Elemental analysis: Anal. Calcd. for
C26H26CuN4O6: Cu, 11.47; C, 56.36; H, 4.73; N, 10.11.
Found: Cu, 11.42; C, 56.33; H, 4.69; N, 10.08%;leff(BM) = 1.96; Km(mho cm
2 mol1) = 20; m/z= 555;
UV–Vis: 348 and 562 nm.
2.4. Antimicrobial activity
The in vitro evaluation of antimicrobial activity was carried
out. The prepared compounds were tested against some fungi
and bacteria to provide the minimum inhibitory concentration
(MIC) for each compound. MIC is the lowest concentration of
solution to inhibit the growth of a test organism. The in vitro
biological screening effects of the investigated compounds
were tested against the bacterial species Staphylococcus aureus,
288 J. Joseph et al.Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris and
Pseudomonas aeruginosa and fungal species Aspergillus niger,
Rhizopus stolonifer, Aspergillus ﬂavus, Rhizoctonia bataicola
and Candida albicans by the well diffusion method. One day
prior to the experiment, the bacterial and fungal cultures were
inoculated in nutrient broth (inoculation medium) and incu-
bated overnight at 37 C. Inoculation medium containing
24 h grown culture was added aseptically to the nutrient med-
ium and mixed thoroughly to get uniform distribution. This
solution was poured (25 ml in each dish) into petri dishes
and then allowed to attain room temperature. Wells (6 mm
in diameter) were cut in the agar plates using proper sterile
tubes. Then, the wells were ﬁlled up to the surface of agar with
0.1 ml of the test compounds dissolved in DMSO (200 lg/ml).
The plates were allowed to stand for an hour in order to facil-
itate the diffusion of the drug solution. Then the plates were
incubated at 37 C for 24 h for bacteria and 48 h for fungi
and the diameter of the inhibition zones was measured. Mini-
mum inhibitory concentrations (MICs) were detected by the
serial dilution method. The lowest concentration (lg/ml) of
compound, which inhibits the growth of bacteria after 24 h
incubation at 37 C, and of fungi after 48 h incubation at
37 C was taken as the MIC. The concentration of DMSO in
the medium did not affect the growth of any of the microor-
ganisms tested.
The interaction of complexes with different microorgan-
isms was studied by UV–Vis spectroscopy. For this, the com-
plex was dissolved in DMSO and added to culture media
(nutrient agar for bacteria and PDA for fungi), containing
the different microorganisms, at concentrations between 25
and 200 lg/ml (1 mM). The spectra were recorded at different
intervals of incubation between 50 min and 24 h (48 h for
fungi).
2.5. SOD activity
In vitro SOD activity was measured using alkaline DMSO as
a source of superoxide radical ðO2 Þ and nitrobluetetrazolium
(NBT) as O2 scavenger. Four hundred microliters sample to
be assayed was added to a solution containing 2.1 ml of
0.2 M potassium phosphate buffer (pH 8.6) and 1 ml of
56 lM NBT. The tubes were kept in ice for 15 min and then
1.5 ml of alkaline DMSO solution was added while stirring.
The absorbance was then monitored at 540 nm against a
sample prepared under similar condition except NaOH which
was absent in DMSO. A unit of superoxide dismutase [SOD]
activity is the concentration of complex or enzyme, which
causes 50% inhibition of alkaline dimethylsulphoxide
(DMSO) mediated reduction of nitrobluetetrazolium chloride
(NBT).
2.6. Reducing power
The complexes (25–800 mM) in DMSO were mixed with 2.5 ml
of phosphate buffer (0.2 M, pH 6.6) and 2.5 ml potassium
ferricyanide [K3Fe(CN)6] (1%), and then the mixture was incu-
bated at 50 C for 30 min afterwards, 2.5 ml of trichloroacetic
acid (10%) was added to the mixture, which was then centri-
fuged at 3000 rpm for 10 min. Finally, 2.5 ml distilled water
and 0.5 ml FeCl3 (0.1%), and the absorbance was measured
at 700 nm. Increased absorbance of the reaction mixture indi-
cated increased reducing power.3. Results and discussion
The Schiff base was prepared according to Scheme 1.
All the complexes are stable at room temperature, insoluble
in water but soluble in DMSO and MeCN. The purity of the
Schiff base ligands and their complexes were checked by TLC.
3.1. Molar conductance
The molar conductance data of the copper complexes were
measured in DMSO solution for the 0.001 M solutions. The
values fall in the range of 10–26 X1 cm2 mol1, which is
the expected range for non-electrolytes (Geary, 1971). Thus,
the present complexes are non-electrolytic in nature as
evidenced by the involvement of acetate group in coordination.
This result was conﬁrmed from the chemical analysis of
CH3COO
 ion is not precipitated by addition of FeCl3. All
the complexes did not show electrolytic properties.
3.2. IR spectra
IR spectra provide a lot of valuable information in coordina-
tion chemistry. In order to study the binding mode of the Schiff
base to the copper in the complexes, the IR spectrum of the
Schiff base ligands was compared with the spectra of the com-
plexes. The IR spectra of the free ligands show the characteris-
tic >C‚N bands in the 1658–1634 cm1 region which are
shifted to lower frequencies in the spectra of the metal com-
plexes (1636–1620 cm1) (Nakamoto, 1986). It conﬁrms the
formation of –C‚N– bonds as well as lack of carbonyl group
from original aldehydic compounds. The complexes also dis-
play bands at 1620–1615 and 1326–1318 cm1 due to the asym-
metric and symmetric stretching vibration of the acetate group
with t= 294 cm1 indicating the coordination of acetate
group. The IR spectra of the metal complexes also show some
new bands in the 480–450 and 450–412 cm1 regions, which
may probably due to the formation of M–O and M–N bands
(Sreeja and Kurup, 2005), respectively. The band observed at
1532 cm1 is due to the mC‚C stretching of the aromatic ring
system. The band observed at 882 cm1 is due to mC–N stretch-
ing vibration of the aromatic nitro group. In all the copper–
Schiff base complexes most of the band shifts observed in the
wave number region 1145–980 cm1 are in agreement with
the structural changes observed in the molecular carbon skele-
ton after complexation, which cause some changes in (C–C)
bond lengths. Thus, the IR spectra results provide strong evi-
dence for the complexation of the potentially bidentate ligand,
i.e., the ligand coordinates to copper atom through azomethine
nitrogen atoms. Another band located at 522 cm1 in the spec-
trum of [Cu(L)(OAc)2] complex may be due to t(M–O) of the
acetate group. The IR spectrum of the ligand (L1) and its cop-
per complex are shown in Fig. 1(A) and (B).
3.3. Electronic spectra
The electronic spectra of the Schiff base ligands and their com-
plexes were recorded in DMSO as a solvent. The spectral data
are given in experimental section. The absorption spectrum of
L1 shows (Fig. 2(A)) a band at 286 nm which is attributed to
n–p* transitions within the Schiff base molecule. The electronic
spectrum of the [CuL1(OAc)2] complex (Fig. 2(B)) in DMSO
Figure 1 IR spectrum of ligand (L1) (A) and [CuL1(OAc)2] complex (B).
Figure 2 UV–Vis spectrum of ligand (L1) (A) and [CuL1(OAc)2] complex (B).
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2B1gﬁ 2A1g transition (Lever, 1968). It reveals that the cop-
per(II) complex exits in square planar geometry. Similar struc-
tural features were assigned for other ligands and their
complexes.
Magnetic susceptibility study of the present [CuL1(OAc)2]
complex gives a magnetic moment value (leff) of 1.96 BM at
room temperature. leff = 1.96 BM indicates one electron
paramagnetism. This value is higher than the spin-only value
of 1.73 BM for one unpaired electron. The higher value of
the magnetic moment indicates that complex is monomeric
in nature and there is no metal–metal interaction along the ax-
ial position in the complex. A similar magnetic behaviour was
assigned for other copper complexes.3.4. 1H NMR spectrum
The 1H NMR spectrum of ligand (L1) was recorded in CDCl3
and displays two singlet at ca. d 1.5 ppm (s, 3H, H3C–C) andca. d 1.8 ppm (s, 3H, H3C–N) due to protons of methyl groups
attached to the pyrazoline rings and at ca. d 7.1–7.9 ppm (m,
13H, aromatic) due to the protons of two aromatic ring and
furfuryl protons. Similar structural features were assigned for
other ligands. All the protons were found to be in their ex-
pected region. The conclusions drawn from these studies lend
further support to the mode of bonding discussed in their IR
spectra. The number of protons calculated from the integra-
tion curves and those obtained from the values of the expected
CHN analyses agree with each other.
The 13C NMR spectrum of ligand (L1) displays the signals
corresponding to the different non-equivalent carbon atoms at
different values of d as follows: at ca. d 10.07 ppm (H3C–C)
and 18.97 ppm (H3C–N) corresponding to carbon atoms of
methyl groups; at ca. d 117.73, 119.92, 121.07 and 125.81 ppm
due to the aromatic carbon atoms; at ca. d 143.23 and
151.07 ppm (H3C–C) due to carbon atom of pyrazoline ring;
at ca. d 153.97 and 152.63 ppm (C‚N) due to carbon atoms
azomethine groups in the furfuryl and aniline moieties. Similar
structural features were observed for other ligands.
Figure 3 FAB mass spectrum of ligand (L1).
Figure 4 FAB mass spectrum of [CuL1(OAc)2] complex.
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Mass spectra provide a vital clue for elucidating the structure
of compounds. The mass spectra of the ligand (L1) and its cop-
per complex [CuL1(OAc)2] were recorded and their stoichiom-
etric compositions were compared as shown in Figs. 3 and 4.
The molecular ion peak for the ligand (L1) is observed at
415 m/z, whereas its copper complex shows the molecular ion
peak at 596 m/z, which conﬁrms the stoichiometry of the cop-
per complexes to be [CuL1(OAc)2]. Elemental analysis values
are in good agreement with the values calculated from molec-Figure 5 ESR spectrum of [CuL1(OAc)2] complex in DMSO
solution at 77 K.ular formula assigned to these complexes, which is further sup-
ported by the FAB-mass studies.
3.6. ESR spectra
The X-band ESR spectrum of the [CuL1(OAc)2] complex was
recorded in DMSO at 300 and 77 K (Fig. 5). The spectrum at
300 K shows one intense absorption band at high ﬁeld, which
is isotropic due to the tumbling motion of the molecules. How-
ever, this complex in the frozen state shows four well resolved
peaks with low intensities in the low ﬁeld region and one in-
tense peak in the high ﬁeld region. The magnetic susceptibility
value reveals that the copper complex has a magnetic moment
of 1.96 BM corresponding to one unpaired electron, indicating
that the complex is mononuclear in nature. This fact was also
evident from the absence of half ﬁeld signal, observed in the
spectrum at 1600 G due to the ms =±2 transitions, ruling
out any Cu–Cu interaction (Raman et al., 2004). The ESR
spectral data are given in Table 1.
The value of gk< 2.3 in the present Cu-complex gives a
clear indication of covalent character of the metal–ligand bond
and delocalisation of the unpaired electron into the ligand. The
trend of gkð2:25Þ > g?ð2:04Þ > geð2:0036Þ describes the axial
symmetry with the unpaired electron residing in the dx2y2 orbi-
tal (Gaballa et al., 2007). For the present Cu(II) complex, the
observed g values are gkð2:25Þ > g?ð2:04Þ > geð2:0036Þ, which
suggest that the unpaired electron lies in the dx2y2 orbital. The
Table 1 ESR spectral data of the copper complexes.
Complex gk g? giso Ak A? Kk K? a
2 b2 c2 f(gk/Ak)
[CuL1(OAc)2] at 300 K 2.06
[CuL1(OAc)2] at 77 K 2.25 2.04 – 155 39 0.92 0.54 0.73 1.2 0.74 145
[CuL2(OAc)2] at 300 K 2.10
[CuL2(OAc)2] at 77 K 2.24 2.06 – 148 44 0.86 0.43 0.76 1.4 0.70 151
[CuL3(OAc)2] at 300 K 2.12
[CuL3(OAc)2] at 77 K 2.26 2.05 – 158 52 0.74 0.49 0.81 1.3 0.82 143
Figure 6 Cyclic voltammogram of [CuL1(OAc)2] complex in
DMSO solution.
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cate that the complex has square planar geometry and the sys-
tem is axially symmetric.
Researchers reported that a good correlation between f fac-
tor (gk/Ak) and SOD like activity of copper complexes. The f
value for CuZn SOD is 160 cm indicating a tetrahedral distor-
tion from square planar geometry and is one of the features
that enhance the catalytic activity of the enzyme. From above
EPR spectral data, the f values for copper complexes were
measured at 152, 148 and 158 cm, respectively. Therefore,
our synthesized copper complexes exhibit appreciable square
planar distortion that is expected to show high SOD like
activity.
The present EPR results show that gk is less than 2.3 in all
the cases suggesting that the copper complexes are covalent in
nature; they show also that gk is in the range of 2.24–2.29,
which is in conformity with the presence of mixed copper–
nitrogen and copper–oxygen bonds in these chelates. Molecu-
lar orbital coefﬁcients a2 (in-plane r-bonding), b2 (in-plane
p-bonding) and c2 (out-plane p-bonding) were calculated using
the following equations:
a2 ¼ ðAk=0:036Þ þ ðgk  2:0036Þ þ 3=7ðg?  2:0036Þ
þ 0:04 ð1Þ
b2 ¼ ðgk  2:0036ÞE= 8ka2 ð2Þ
c2 ¼ ðg?  2:0036ÞE= 2ka2 ð3Þ
The a2 value of 0.5 indicates complete covalent bonding,
while that of 1.0 suggests complete ionic bonding. The ob-
served value of 0.7325 for the present complex indicates that
the copper complex has some covalent character. The observed
b2 and c2 values of 1. 256 and 0.7427 indicate that there is
interaction in the out-of-plane p-bonding, whereas the in-plane
p-bonding is predominantly ionic. Signiﬁcant information
about the nature of bonding in the Cu(II) complex can be de-
rived from the relative magnitudes of Kk and K?:
Kk ¼ a2b2 ð4Þ
K? ¼ a2c2 ð5Þ
For the present complex, the observed order: Kkð0:92Þ >
K?ð0:544Þ implies a greater contribution from out-of plane
p-bonding than from in in-plane p-bonding in metal–ligand
p bonding.
3.7. Cyclic voltammetry
The cyclic voltammogram of the [CuL1(OAc)2] complex in
acetonitrile solution at 300 K in the potential range +0.4 to0.8 V at scan rate 0.1 V s1 was recorded (Fig. 6). It shows
a well deﬁned redox process corresponding to the formation
of the quasi-reversible Cu(II)/Cu(I) couple. The anodic peak
at Epa = 0.16 V versus Ag/AgCl and the associated cathodic
peak at Epc = 0.32 V correspond to the Cu(II)/Cu(I) couple.
The [CuL1(OAc)2] complex exhibits a quasi-reversible behav-
iour as indicated by the non-equivalent current intensity of
cathodic and anodic peaks. The quasi reversible behaviour of
this complex is also supported by the presence of large peak
separation of Epa and Epc.
The cyclic voltammogram of the [CuL2(OAc)2] complex in
acetonitrile solution at 300 K in the potential range +0.4 to
0.8 V at scan rate 0.1 V s1 was recorded. It shows a well de-
ﬁned redox process corresponding to the formation of the qua-
si-reversible Cu(II)/Cu(I) couple. The anodic peak at
Epa = 0.16 V versus Ag/AgCl and the associated cathodic
peak at Epc = 0.32 V correspond to the Cu(II)/Cu(I) couple.
The [CuL2(OAc)2] complex exhibits a quasi-reversible
behaviour.
The cyclic voltammogram of the [CuL3(OAc)2] complex in
acetonitrile solution at 300 K in the potential range +0.4 to
0.8 V at scan rate 0.1 V s1 was recorded. It shows a well de-
ﬁned redox process corresponding to the formation of the qua-
si-reversible Cu(II)/Cu(I) couple. The anodic peak at
Epa = 0.16 V versus Ag/AgCl and the associated cathodic
peak at Epc = 0.32 V correspond to the Cu(II)/Cu(I) couple.
The [CuL3(OAc)2] complex exhibits a quasi-reversible
behaviour.
Electrochemical studies reveal that the introduction of elec-
tron withdrawing groups render the reduction of Cu(II) easier
than the electron releasing groups in the Schiff base complexes.
Therefore, [CuL2(OAc)2] complex has higher activity than the
other complexes.
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The powder XRD pattern of copper complexes was measured.
The diffraction pattern reveals the crystalline nature of the
copper complex. The crystallite size of the copper complexes
was calculated from Scherre’s formula:
dXRD ¼ 0:9k=b cos h
where k is the wavelength; b is the full-width half maximum of
the characteristic peak and h is the diffraction angle for the
h k l plane.
From the observed dXRD patterns, the average crystallite
sizes for the Cu(II) complexes of L1–L3 are found to be 67
(as shown in Fig. 7), 58 and 72 nm, respectively. The appear-
ance of crystallinity in the Cu(II) complex is due to the inher-
ent crystalline nature of the copper compounds.
4. Antimicrobial activity
The in vitro biological screening effects of the investigated
compounds were tested against the bacterial species S. aureus,
E. coli, K. pneumoniae, P. vulgaris and P. aeruginosa and
fungal species A. niger, R. stolonifer, A. ﬂavus, R. bataicola
and C. albicans by the well diffusion method. The minimum
inhibitory concentration (MIC) values of the compounds are
summarized in Tables 2 and 3. A comparative study of the
ligands and their complexes (MIC values) indicates that com-
plexes exhibit higher antimicrobial activity than the free ligands.
The enhanced activity of the complexes can be explained on
the basis of Overtone’s concept (Belaid et al., 2008) and Twee-
dy’s Chelation theory (Dharamaraj et al., 2001). According to
Overtone’s concept of cell permeability, the lipid membrane
that surrounds the cell favors the passage of only the lipid-
soluble materials makes which liposolubility as an important
factor, which controls the antimicrobial activity. On chelation,
the polarity of the metal ion will be reduced to a greater extent
due to the overlap of the ligand orbital and partial sharing of
the positive charge of the metal ion with donor groups. Fur-
ther, it increases the delocalization of p-electrons over theFigure 7 Powder XRD patterwhole chelate ring and enhances the lipophilicity of the com-
plexes. This increased lipophilicity enhances the permeation
of the complexes into lipid membranes and blocking of the me-
tal binding sites in the enzymes of microorganisms. These com-
plexes also disturb the respiration process of the cell and thus
block the synthesis of the proteins that restricts further growth
of the organism and as a result microorganisms die.
The increased activity of the complexes may also be ex-
plained on the basis of their high solubility, ﬁtness of the par-
ticles, size of the metal ion and the presence of the bulkier
organic moieties. Presumably, the different lipophilic behav-
iour of the aromatic residues such as antipyrine, aniline and
furfuryl is involved in the biological activity mechanisms. In
fact, log P values of antipyrine (0.26), aniline (0.9) and furfuryl
(0.93) give a clear indication that these residues are endowed
with an increased lipophilicity and, so, with a higher capability
to penetrate the microorganisms.4.1. Interaction of copper complexes with microorganisms
Copper complexes are biologically active due to redox pro-
cesses involved in their observed biological activity. [Cu-
L1(OAc)2] in DMSO was mixed in culture media with
different microorganisms (1 mM as ﬁnal concentration) and
their UV–Vis spectra were recorded at different times of incu-
bation. The band of [CuL1(OAc)2] complex in the culture med-
ia at about 410 nm disappeared after interacting with the
different microorganisms. It is important to note that [Cu-
L1(OAc)2] complex shows a band at 332 nm indicating that a
ﬁrst transformation of the complex occurred immediately
(shift to 410 nm) with a second change at 24 h. The disappear-
ance of the characteristic band of a Cu(I) complex at 332 nm
indicates that a redox process took place.
The observed variation in the activity of the copper com-
plexes across the various classes of organisms studied may be
attributable to differences in cell wall and/or membrane con-
struction (gram-positive bacteria; peptidoglycan and teichoic
acid; gram-negative bacteria; peptidoglycan and liposaccha-
ride). It is expected that the more extensive heteroaromaticn of [CuL1(OAc)2] complex.
Table 4 Superoxide dismutase activity of some copper(II)
complexes.





Table 2 Minimum inhibitory of concentration of the synthesized compounds against growth of bacteria
(lg/ml).
S. No. Compound E. coli K. pneumoniae P. vulgaris P. aeruginosa S. aureus
1 L1 60 64 66 66 72
2 L2 24 26 20 16 28
3 L3 28 36 26 32 30
4 [CuL1(OAc)2] 34 38 32 28 42
5 [CuL2(OAc)2] 26 28 30 26 48
6 [CuL3(OAc)2] 52 54 58 60 63
7 PenicillinG 10 15 6 12 4
8 Ampicillin 12 10 8 4 6
9 Vancomycin 6 14 12 10 8
10 Oﬂoxacin 8 10 4 6 14
Table 3 Minimum inhibition of concentration of the synthesized compounds against growth of fungi (lg/ml).
S. No. Compound A. niger R. stolonifer A. ﬂavus R. bataicola C. albicans
1 L1 60 66 72 80 50
2 L2 19 20 20 25 22
3 L3 24 28 28 34 30
4 [CuL1(OAc)2] 28 30 34 38 22
5 [CuL2(OAc)2] 32 26 46 36 6
6 [CuL3(OAc)2] 52 55 68 80 50
7 Nystatin 10 16 8 14 12
8 Ketoconazole 12 8 16 6 12
9 Clotrimazole 8 6 12 10 4
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C‚N would confer greater lipophilicity on [CuL(OAc)2] and
enable it to penetrate the cell wall and promote adverse intra-
cellular interactions. Among the studied compounds, [Cu-
L2(OAc)2] (MIC 6 lg/ml) complex showed good antifungal
activity against C. albicans. It is very harmful to humans we
consider this result of major importance.
5. Reducing power
The reducing power of the complexes may serve as a tool for
its antioxidant activity. The copper complexes were tested
for their relative reducing capacities. The antioxidant activities
of putative antioxidants may be attributed to various mecha-
nisms, such as prevention of chain initiation, decomposition
of peroxides, prevention of continued hydrogen abstraction
and radical scavenging. In the present work, [CuL2(OAc)2]
complex has low reducing power and has high total antioxi-
dant activity than other Cu(II) complexes. Since, the reducing
power of above complexes was found to be signiﬁcant in this
study. Therefore, this may be considered as potential antioxi-
dants capable of generating copper(II) ligand radical.
6. SOD activity
A great deal of interest has been shown in the development of
therapeutic SOD mimetics for the scavenging of superoxide
ðO2 Þ which is a precursor to reactive oxygen and nitrogen spe-
cies (RONS) known to contribute to oxidative stress.
The SOD mimetic activities of the copper(II) complexes
were determined and compiled in Table 4. In the present com-
plexes, the higher SOD activity is [CuL2(OAc)2] due to electron
withdrawing substituent compared to other complexes. Agreater interaction between superoxide ion and Cu(II) complex
is induced due to the stronger axial bond, which results in an
increased catalytic activity. In addition azomethine ligands
containing electron withdrawing substituent stabilizes the
Cu(I) complex formed during superoxide dismutation reaction
which further reacts with superoxide ion to give hydrogen per-
oxide. The distorted geometry of these complexes may favor
the geometrical change, which is essential for the catalysis as
the geometry of copper in the SOD enzyme also changes from
distorted square planar geometry.
The difference in reactivities of the synthesized complexes
may be attributed to the coordination environment and the re-
dox potential of the couple Cu+/Cu++ in copper(II) com-
plexes during the catalytic cycle. It has been reported that
the redox potential of copper(II) ions is affected by the coordi-
nation structure of copper(II) complexes. The nature of substi-
tuent plays a key role in stabilizing the Cu+ oxidation state
during the catalytic cycle.
7. Conclusion
4-Aminoantipyrine derivatives and their copper complexes
were synthesized and characterized. Based on the above
294 J. Joseph et al.observations of the elemental analysis, molar conductivity,
UV–Vis, magnetic and IR spectral data it is possible to deter-
mine the type of coordination of the ligands in their copper
complexes. The spectral data show that all the Schiff bases ex-
ist as bidentate ligands by bonding to the copper ion through
the azomethine nitrogen atoms. They have adopted square pla-
nar geometry around the copper(II) ion. The antimicrobial
studies data reveal that the copper complexes act as more bac-
tericidal and fungicidal agents as compared to the uncom-
plexed Schiff base ligand and the copper acetate from which
they are derived. The synthesized complexes exhibit signiﬁcant
SOD mimetic and reducing power activities.Acknowledgements
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